CYT003-QbG10 for Treatment of Allergic Asthma Bronchial
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 65 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Persistent allergic asthma bronchial requiring long-term treatment with inhaled corticosteroids
Further criteria as defined in the study protocol
Use of oral corticosteroids within past 3 months
Hospitalization for asthma exacerbation within past 6 months